The study investigates the outcomes and complications associated with the use of Impella mechanical circulatory support in patients experiencing cardiogenic shock after acute myocardial infarction over a 12-year period.
A total of 172 patients were treated with Impella, showing high short-term mortality rates of 56.2% at 30 days and 60.7% at 6 months, alongside various complications such as vascular issues and bleeding.
The analysis identified that pre-treatment pH levels are a significant predictor of 6-month mortality in these patients, indicating a need for more targeted interventions.